Specific Cases For Treatment And Management Of Gerstmann Syndrome
Published on: March 30, 2025
Specific Cases For Treatment And Management Of Gerstmann Syndrome
Article author photo

Beyza Çetin

Bachelor's degree, Molecular Biology and Genetics, Biruni Üniversitesi

Article reviewer photo

Riya Gurung

BSc in Biology, Queen Mary University of London

What is gerstmann syndrome?

Gerstmann Syndrome (GS) is an uncommon neurological disorder characterized by cognitive alterations that correspond to four symptoms: acalculia, agraphia, right-left disorientation, and finger agnosia. Certain brain injuries, particularly those affecting the angular gyrus (a part of the brain with roles in language processing and reading) and surrounding areas, have been reported to produce similar outcomes. In addition, the possibility of disconnection syndrome, a group of neurological disorders, should be considered in specific cases.1,3

  • Agnosia: incapacity to identify, name, and differentiate between the fingers
  • Agraphia: developed disruption in the capacity for writing
  • Acalculia: lack of the capacity to employ numerical ideas and execute mathematical tasks
  • Right-left disorientation:  difficulty in right-left determination11

 Although this disease has a similar name to the Gerstmann-Sträussler-Scheinker disease, , it must be noted that they are totally different.4

Information about case reports

There are rare cases of the syndrome in youngsters, sometimes known as developing Gerstmann's syndrome, but the cause remains unknown. The majority of instances are identified when children reach school age and are required to complete writing and arithmetic activities. Typically, children with Gerstmann syndrome exhibit poor handwriting, spelling skills and difficulty with math functions such as addition, subtraction, multiplication, and division. They may also be unable to discriminate between right and left hands, as well as specific fingers. Many children also suffer from constructional apraxia, which is the inability to reproduce simple designs and reading skills are usually affected. It may impact both youngsters with good intellectual functioning and those who have undergone brain damage.4

A unique case

A rare and complex presentation was discovered as an ischemic stroke, which occurs when blood supply to the brain is cut off by a blockage. This led to a hemorrhagic conversion (bleeding in the brain), resulting in Gerstmann syndrome symptoms. Subsequently, it was realised that this individual’s condition was brought on by secondary polycythemia (overproduction of blood cells) after long-term use of anabolic steroids that are generally taken to improve athletic performance.5

Treatment

There is no treatment option for Gerstmann Syndrome; thus, the therapeutic approach can only be supportive. Patients experiencing symptoms can choose to participate in clinical research as volunteers to advance research in fast detection and treatment for symptoms.4

Causes

There are potential causes for this syndrome, such as ischemic stroke, carotid artery dissection due to aneurysm or stenosis, several cancer types, cerebral aneurysm located in the middle artery, chronic subdural hematoma, multiple sclerosis, and cortical atrophy.6

Cerebrovascular disease, which is defined by decreased blood flow to the brain after a stroke or other brain trauma, can cause the syndrome in adults. The parietal lobes, or top side lobes, of the brain are affected by Gerstmann syndrome. The parietal lobes mediate processes related to sensation, perception, and the understanding of sensory information. Rarely, a brain tumor or severe brain injury in the same region of the brain might cause the many symptoms associated with Gerstmann syndrome. The origin of children's Gerstmann syndrome is often unknown, but children without brain damage can also be affected.7

The pathophysiology

The pathogenesis (development of a disease) of Gerstmann syndrome is mostly dependent on the involvement of the supramarginal and angular gyri (plural for gyrus) in the dominant parietal lobe, particularly the loss of white fibers in that area.8 These nerve fibres are extremely crucial, as they enable different parts of the brain to communicate for various functions, and this includes language and speech for this specific area of the brain.  The pathophysiology of Gerstmann syndrome is similar to that of Parkinson's disease, and the disconnection syndrome is thought to be caused by injuries to association fibers connecting various cortical and subcortical regions.9,10 Therefore, this suggests that deep brain stimulation, the surgical procedure that improves movement in Parkinson’s, may also play a part in treating Gerstmann syndrome.8

Natalizumab use

A research report describes a thirty-year-old woman with Gerstmann's disease. An MRI of the left cerebral hemisphere revealed a large lesion (damage to the relevant tissue). The usual treatment, intravenous corticosteroids,  did not reverse the disease's progression.  Initially,  the signs pointed to a tumour or cerebral lymphoma, but the brain biopsy confirmed inflammatory demyelination, which is when the immune system mistakenly attacks the myelin sheath surrounding the nerve fibres and damages them. Following the identification of tumefactive multiple sclerosis, treatment with natalizumab resulted in a considerable reduction in disease activity.12 Natalizumab is taken as an infusion or injection by people with multiple sclerosis, and it works by attaching itself to the T cells in your immune system, which prevents them from reaching the brain and attacking the myelin sheath. 

Gerstmann’s syndrome in active relapsing-remitting multiple sclerosis with cognitive deficits

Gerstmann's syndrome has been observed when severely active relapsing multiple sclerosis is paired with significant cognitive deficits.12,13

A patient with gerstmann syndrome & antidepressants

A patient who was temporarily laid off due to his depression, later came to the hospital presenting with Gerstmann's syndrome. The angiography (used to check blood vessels) showed a dural arteriovenous fistula (DAVF), which is an abnormal connection between the artery and a vein in the dura mater (protective membrane of the brain and spinal cord) that can lead to bleeding in the brain. Treatments for the DAVF included endovascular surgery and coil embolization, which improved his melancholy and Gerstmann's health. The patient's antidepressant dose was lowered during the therapy, and two years later, they resumed work without the need for antidepressants. As the patient fully ceased their use of antidepressants two years after starting treatment, DAVFs are believed to be a contributing factor in depression.14

Diagnosis process and procedure

Gerstmann's syndrome is associated with lesions or malfunctioning of the left angular gyrus in the parietal lobe.15 A tuberculous brain abscess in the left parietal lobe afflicted a patientand it was the source of both right-sided apraxia and Gerstmann's syndrome. It is difficult to diagnose Gerstmann's condition since aphasia is usually present.16 Communication and understanding fluency are usually impaired. The patient was able to explain the typical characteristics of Gerstmann's disease since they did not have aphasia,  resulting in a simple diagnosis.17

Steroid use correlation with gerstmann syndrome

Chronic usage of steroids has been connected to problems with the neurological system, musculoskeletal system, heart, and reproductive system. Cardiomyopathy (a group of heart conditions that reduce its ability to pump blood around the body) and secondary erythrocytosis (excess of red blood cells being produced) can raise the risk of stroke among users without any other risk factors, despite the fact that there aren't many recorded occurrences of strokes linked to anabolic steroid use. Among those who utilize anabolic steroids are bodybuilders and athletes.  Due to long-term usage of anabolic steroids,  a 49-year-old man had hemorrhagic conversion and hypercoagulability (increased risk for blood clot formation), which in turn caused the onset of Gerstmann syndrome.18

Transient gerstmann syndrome during DAVF treatment

In an assessment of DAVFs, it was noted that following a blood vessel rupture, one patient out of 157 procedures experienced temporary Gerstmann syndrome. Nonetheless, no further irreversible neurological deficits were seen, suggesting that endovascular (inside the vessel) treatment of DAVFs does not typically result in significant side effects similar to Gerstmann syndrome.19

Endovascular embolization for mild gerstmann syndrome

In this case, a large middle cerebral artery (MCA) serpentine aneurysm (named due to the shape) was the source of a 44-year-old man's migraines and seizures. The aneurysm was large, thrombosed (clot formed), and resembled a mass-like lesion that kept overflowing into the MCA's l surrounding branches. After completing a balloon occlusion test (BOT) to assess collateral circulation, an endovascular embolization was performed on the MCA artery. An endovascular embolization procedure blocks off blood flow from a specific blood vessel to prevent excessive bleeding or cut off abnormal connections between vessels. After the procedure, the patient experienced mild Gerstmann syndrome, but she was discharged in a cognizant state. On follow-up imaging, there was a reduced mass effect, and the patient's Gerstmann syndrome improved. Endovascular embolization is shown to be an effective therapy for a large serpentine aneurysm after a balloon occlusion test evaluation.20

Management of gerstmann syndrome in a patient with MALT lymphoma after chemotherapy

The week after beginning MALT lymphoma (a type of cancer) therapy, a 60-year-old man was admitted to the hospital with abrupt speech problems, Gerstmann syndrome, and incomplete right hemiparesis (one-sided muscle weakness). An MRI of his brain showed left-sided bleeding, and additional testing revealed two middle cerebral artery (MCA) aneurysms that had grown bigger over the preceding two weeks. Using a blood artery from his head, medical professionals conducted bypass surgery after the aneurysms were removed. The aneurysm walls' histological analysis revealed no evidence of malignant or infected cells, which was most likely the cause of the aneurysms Considering how effective the treatment was, the lymphoma cells might have vanished. Reconstructing the scalp blood artery is one surgical method for treating a ruptured MCA, although this form of aneurysm is extremely uncommon.21

Summary

Gerstmann Syndrome (GS) is a rare neurological disorder characterized by four key symptoms: acalculia (inability to perform math), agraphia (difficulty with writing), right-left disorientation, and finger agnosia (inability to identify fingers). It is typically caused by damage to the angular gyrus in the dominant parietal lobe, often due to cerebrovascular events like strokes, brain tumors, or trauma. Though there is no specific treatment for GS, supportive care is provided, and clinical research offers insights for future treatment options. The syndrome can also occur in children, sometimes with no clear brain injury. Certain medical conditions like multiple sclerosis and dural arteriovenous fistulas (DAVFs) can also be linked to GS. Treatment often involves managing the underlying cause, such as using natalizumab for multiple sclerosis or endovascular procedures for DAVFs. Additionally, long-term steroid use, especially anabolic steroids, has been associated with increased stroke risk, potentially leading to GS.

References

  1. João RB, Filgueiras RM, Mussi ML, de Barros JEF. Transient Gerstmann syndrome as manifestation of stroke: Case report and brief literature review. Dement Neuropsychol. 2017 Apr-Jun;11(2):202-205. doi: 10.1590/1980-57642016dn11-020013. PMID: 29213512; PMCID: PMC5710689.
  2. Al-Samaraie AAS. Gerstmann Syndrome Case-Control Study: Correlation between Brain Lesions & Functional Disability. Int Tinnitus J. 2024 Mar 21;27(2):247-252. doi: 10.5935/0946-5448.20230038. PMID: 38507641.
  3. KINSBOURNE M, WARRINGTON EK. The developmental Gerstmann syndrome. Arch Neurol. 1963 May;8:490-501. doi: 10.1001/archneur.1963.00460050040004. PMID: 14032921.
  4. National Institute of Neurological Disorders and Stroke. Gerstmann’s syndrome. National Institute of Neurological Disorders and Stroke. 2023. Available from: https://www.ninds.nih.gov/health-information/disorders/gerstmanns-syndrome#:~:text=There%20is%20no%20cure%20for,children%20cope%20with%20the%20symptoms.
  5. Long N, Bassi S, Pepito D, Akhondi H. Gerstmann syndrome complicating polycythemia secondary to anabolic steroid use. BMJ Case Rep. 2019 Jun 6;12(6):e229004. doi: 10.1136/bcr-2018-229004. PMID: 31175112; PMCID: PMC6557380.
  6. Altabakhi IW, Liang JW. Gerstmann Syndrome. 2023 Aug 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30137813.
  7. National Organization for Rare Disorders. Gerstmann syndrome. National Organization for Rare Disorders. 2023. Available from: https://rarediseases.org/rare-diseases/gerstmann-syndrome/#causes
  8. Alare K, Abioye E, Saydo B. Gerstmann Syndrome: What is the Possible Role of Deep Brain Stimulation? Neurocrit Care. 2024 Jun 24. doi: 10.1007/s12028-024-02013-2. Epub ahead of print. PMID: 38914905.
  9. Catani M, Mesulam M. What is a disconnection syndrome? Cortex. 2008 Sep;44(8):911-3. doi: 10.1016/j.cortex.2008.05.001. Epub 2008 May 23. PMID: 18603236.
  10. Yoon SH, Lee JI, Kang MJ, Lee HI, Pyun SB. Gerstmann Syndrome as a Disconnection Syndrome: A Single Case Diffusion Tensor Imaging Study. Brain Neurorehabil. 2023 Mar 14;16(1):e3. doi: 10.12786/bn.2023.16.e3. PMID: 37033002; PMCID: PMC10079479.
  11. Ardila A. Gerstmann syndrome. Curr Neurol Neurosci Rep. 2020;20(48). Available from: https://doi.org/10.1007/s11910-020-01069-9
  12. Gnanapavan S, Jaunmuktane Z, Baruteau KP, Gnanasambandam S, Schmierer K. A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome. BMC Neurol. 2014 Apr 2;14:68. doi: 10.1186/1471-2377-14-68. PMID: 24694183; PMCID: PMC4021226.
  13. Ehrlé N, Maarouf A, Chaunu MP, Sabbagh-Peignot S, Bakchine S. Syndrome de Gerstmann acquis ou développemental. Illustration chez une patiente atteinte de sclérose en plaques [Acquired and developmental Gerstmann syndrome. Illustration from a patient with multiple sclerosis]. Rev Neurol (Paris). 2012 Nov;168(11):852-60. French. doi: 10.1016/j.neurol.2011.11.006. Epub 2012 May 5. PMID: 22560518.
  14. Nakagawa M, Sugiu K, Tokunaga K, Sakamoto C, Fujiwara K. Improvement of depression after treatment of dural arteriovenous fistula: a case report and a review. Case Rep Psychiatry. 2012;2012:730151. doi: 10.1155/2012/730151. Epub 2012 Nov 28. PMID: 23243544; PMCID: PMC3515890.
  15. Carota A, Di Pietro M, Ptak R, Poglia D, Schnider A. Defective spatial imagery with pure Gerstmann's syndrome. Eur Neurol. 2004;52(1):1-6. doi: 10.1159/000079251. Epub 2004 Jun 22. PMID: 15218337.
  16. Rusconi E, Pinel P, Dehaene S, Kleinschmidt A. The enigma of Gerstmann's syndrome revisited: a telling tale of the vicissitudes of neuropsychology. Brain. 2010 Feb;133(Pt 2):320-32. doi: 10.1093/brain/awp281. Epub 2009 Nov 10. PMID: 19903731.
  17. Kuo CL, Lo SF, Liu CL, Chou CH, Chou LW. Effect of rehabilitation on a patient suffering from a tuberculous brain abscess with Gerstmann's syndrome: case report. Neuropsychiatr Dis Treat. 2012;8:217-20. doi: 10.2147/NDT.S31713. Epub 2012 May 7. PMID: 22665998; PMCID: PMC3363139.
  18. Long N, Bassi S, Pepito D, Akhondi H. Gerstmann syndrome complicating polycythemia secondary to anabolic steroid use. BMJ Case Rep. 2019 Jun 6;12(6):e229004. doi: 10.1136/bcr-2018-229004. PMID: 31175112; PMCID: PMC6557380.
  19. Tsumoto T, Terada T, Tsuura M, Matsumoto H, Yamaga H, Masuo O, Itakura T. Analysis of Complications related to Endovascular Therapy for Dural Arteriovenous Fistulae. Interv Neuroradiol. 2004 Mar 30;10 Suppl 1(Suppl 1):121-5. doi: 10.1177/15910199040100S121. Epub 2008 Jun 9. PMID: 20587287; PMCID: PMC3490159.
  20. Jeong YH, Kim JY, Koo YM, Choi JW, Whang K, Hu C, Cho SM. Endovascular Treatment of Giant Serpentine Aneurysm of the Middle Cerebral Artery. J Cerebrovasc Endovasc Neurosurg. 2016 Sep;18(3):264-270. doi: 10.7461/jcen.2016.18.3.264. Epub 2016 Sep 30. PMID: 27847772; PMCID: PMC5104853.
  21. Hasegawa Y, Morioka M, Makino K, Kai Y, Hamada J, Kuratsu J. Arterial graft to treat ruptured distal middle cerebral artery aneurysms in a patient with mucosa-associated lymphoid tissue lymphoma. Case report. Neurol Med Chir (Tokyo). 2012;52(6):443-5. doi: 10.2176/nmc.52.443. PMID: 22729079.
Share

Beyza Çetin

Bachelor's degree, Molecular Biology and Genetics, Biruni Üniversitesi

Beyza Çetin is a 4th-year MPharm student at Biruni University’s Faculty of Pharmacy, where she began her studies in 2021. Passionate about healthcare, she actively engages in pharmacy-related events, such as congresses, symposia, and panels, enjoying discussions with peers about academic experiences.

Beyza also participates in webinars and online seminars, focusing on topics in sleep and circadian health (Thomas F. Anders, TUM) and journal clubs (SCMR, EPNS), where she learns from leading experts. As the IPSF EuRO Regional Assistant and a member of the WHO Youth4Health network, she connects with young health advocates to address global health challenges.

Her professional experience includes being an EPSA Science! Monthly Author, where she wrote articles on Antimicrobial Stewardship and Biotherapeutics. Since July 2024, she has been a Klarity Educational Medical Writing Intern, producing articles on topics such as Gaucher Disease and Cerebellar Ataxia.

Beyza Çetin is an internal and external relations member of the Eczacılar Burada platform(2024), where she engages with pharmacy professionals to enhance communication and collaboration within the field. Additionally, she contributed to the Neuromer Journal Club, presenting on the use of amantadine in traumatic brain injury, further enriching her knowledge and experience in neuroscience.

Beyza is recognized for her strong organizational skills, attention to detail, and adaptability. A proactive team player, she values open communication and approaches tasks with a sense of responsibility, highlighting her commitment to continuous improvement in the pharmaceutical field.

arrow-right